STAT July 10, 2024
Elaine Chen

Good morning. It’s been a challenging time for workers in the biopharma industry. We’ve seen companies announce layoffs one after another, and people online talk about how it seems increasingly difficult to secure a new job. Read our latest on this subject below, with new numbers on the state of the job market.

The need-to-know this morning

  • Flagship Pioneering raised a new $2.6 billion investment fund, plus an additional $1 billion for sector-specific side funds. This brings the total capital raised by Flagship into its funds since 2021 to $6.4 billion.
  • Abbvie named a new R&D chief. Roopal Thakkar takes over as chief scientific officer and executive vice president for R&D, replacing the retiring Thomas Hudson. Thakkar is currently...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Share This Article